# Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

> **NCT00586625** · PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 861 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Bepreve
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00586625
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-05
- **Final completion:** —
- **Target enrollment:** 861 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00586625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00586625, "Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00586625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*